Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer

Immunomodulator-targeting therapies are under development in gastric cancer (GC). However, the role of genes modulating anti-tumor immunity in GC remains poorly understood. We investigated the association of variations in genes involved in immunomodulatory pathways with overall survival (OS) in loco...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmacogenomics J
Asıl Yazarlar: Sunakawa, Y, Cao, S, Volz, NB, Berger, MD, Yang, D, Parekh, A, Zhang, W, Matsusaka, S, Ning, Y, Stremitzer, S, Stintzing, S, Sebio, A, Okazaki, S, Wakatsuki, T, Azuma, M, Watanabe, M, Koizumi, W, Wu, AH, Lenz, H-J
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7507965/
https://ncbi.nlm.nih.gov/pubmed/27241062
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/tpj.2016.46
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller